IMR Press / FBL / Volume 8 / Issue 6 / DOI: 10.2741/1029

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
From Lewy body disease to Alzheimer's disease: hypothesis and evidence
Show Less
1 Department of Neuropathology, Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA
Front. Biosci. (Landmark Ed) 2003, 8(6), 223–227; https://doi.org/10.2741/1029
Published: 1 May 2003
Abstract

The mechanisms underlying Alzheimer's disease and Lewy body disease have long been a controversial subject among neurologists and neuropathologists. Here, we hypothesize that three most common histopathological structures, Lewy body (LB), neurofibrillary tangle (NFT) and neuritic senile plaque (NP) found in neurodegenerative diseases are different stages of the same lesion. Lewy body disease (LBD) and Alzheimer's disease (AD) are based on a similar or the same pathogenic mechanism. Different clinical manifestations and pathological features found in postmortem brains between LBD and AD is due to the different intensities of initial insults, rate of the disease progression and temporal involvement of different brain regions during the AD development.

Keywords
Alzheimer’s disease
Lewy Body
Amyloid
α-Synuclein
Tau
Share
Back to top